CDC27

STAINING OVERVIEW

? »

Overall cancer tissue 
staining statistics


0%
25%
50%
75%
100%

Tissue presentation order

Histological

Alphabetical

 

Antibody HPA028129

Antibody CAB004357

Antibody CAB016315

Tissue

Antibody staining

Antibody staining

Antibody staining

Colorectal cancer
Breast cancer
Prostate cancer
Ovarian cancer
Cervical cancer
Endometrial cancer
Carcinoid
Head and neck cancer
Thyroid cancer
Glioma
Lymphoma
Lung cancer
Melanoma
Skin cancer
Testis cancer
Urothelial cancer
Renal cancer
Stomach cancer
Pancreatic cancer
Liver cancer

Summary

Most malignancies displayed moderate to strong nuclear staining combined with cases of cytoplasmic positivity. Non-hodgkin's lymphomas, prostate and renal cell carcinomas were weakly stained or negative in several cases.A majority of malignancies showed moderate to strong cytoplasmic and/or nuclear positivity. Most cases of malignant gliomas, prostate, endometrial, pancreatic and liver cancers were weakly stained or negative. Malignancies generally displayed moderate to strong nuclear positivity. A majority of adenocarcinomas in lung, hepatocellular, prostate and renal cancers were weakly stained or negative.

Literature conformity

Consistent with extensive gene/protein characterization dataPartly consistent with extensive gene/protein characterization dataConsistent with extensive gene/protein characterization data

Level of antibody staining/expression





High
Medium
Low
Not detected